Skip to Main Content

Paper Details

Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
Gastroenterology
56
2021
CD4, CD8, CD8 T cell, DNA mismatch repair deficiency, FSP, FSP neoantigen, FSP neoantigens, FSP-1, LS, LS cancer, Lynch Syndrome, Lynch syndrome, MSI, MSI cancer, MSI tumors, Maz, Mouse, Msh2, Nacad, Senp6, Tumor, Xirp1, cancer, cancer-related genes, colorectal cancer, hereditary cancer syndrome, intestinal cancer, intestinal tumor, mice, microsatellite, mismatch repair genes, mononucleotide, mouse, mouse coding mononucleotide repeats, naproxen, patients, tumor
Author NameAffiliation
Elena TostiAlbert Einstein College of Medicine
Eduardo VilarThe University of Texas MD Anderson Cancer Center
Robert H ShoemakerNational Cancer Institute
Robert H ShoemakerNational Cancer Institute
Peer BorkUniversity of Wurzburg
Peer BorkUniversity of Wurzburg
Winfried EdelmannAlbert Einstein College of Medicine
  • 1 - 7

Datasets

Release 1.2